BRAIN Initiative: Biology and Biophysics of Neural Stimulation and Recording Technologies (R01 Clinical Trials Optional) | RFA NS 20 006

Frequently Asked Questions (FAQs)

1) What is this funding opportunity?

This opportunity is the NIH BRAIN Initiative funding announcement titled "Biology and Biophysics of Neural Stimulation and Recording Technologies (R01 Clinical Trials Optional)" with Funding Opportunity Number RFA-NS-20-006. It supports research that improves the evidence-based scientific understanding of how existing neural stimulation and neural recording technologies interact with the nervous system.

2) What is the main goal of the FOA?

The main goal is to clarify what commonly used stimulation and recording tools are actually doing biologically and what the signals they produce truly mean. The FOA emphasizes building a mechanistic and interpretive foundation so neuroscience studies can use current tools more predictably and interpret results more accurately.

3) Is this opportunity about inventing new devices or platforms?

No. Developing entirely new technologies is stated as outside the scope. The focus is on understanding and validating the biological interactions and interpretability of technologies already in use.

4) Is therapeutic or translational development within scope?

No. Therapeutic development efforts and pushing toward therapeutic translation are described as outside the scope of this FOA.

5) Are new disease models supported under this FOA?

No. The creation of new disease models is explicitly described as outside the scope.

6) What types of research does the FOA support overall?

The FOA supports research that systematically characterizes, models, and validates: (a) biological responses to neural stimulation technologies and (b) the biological meaning and bioinformatic content of signals captured by neural recording technologies. The emphasis is on mechanisms, interpretation, and context dependence rather than tool invention.

7) What are the two research tracks described in the announcement?

The FOA invites applications in two connected but distinct tracks: (1) a stimulation-focused track and (2) a recording-focused track.

8) What is the stimulation-focused track looking for?

Projects in the stimulation track should characterize, model, and validate biological responses produced by different stimulation technologies. The FOA highlights multi-scale work spanning membrane biophysics, cellular physiology, circuit-level effects, and longer-term adaptive responses that may occur with repeated or chronic stimulation.

9) Does the stimulation track only focus on neurons?

No. The FOA explicitly includes non-neuronal cells, noting that glia, vasculature-associated cells, and other neural tissue components can shape or be altered by stimulation in ways that affect interpretation and outcomes.

10) What kinds of outputs are expected from stimulation-track projects?

The FOA indicates an expectation for rigorous experimental and/or computational frameworks that clarify mechanisms, thresholds, variability, and context dependence of stimulation effects, enabling more predictable use and more accurate interpretation in future studies.

11) What is the recording-focused track looking for?

Projects in the recording track should determine the biological meaning and bioinformatic content of signals captured from neural cells and circuits. The aim is to understand what recorded signals represent and how they relate to underlying cellular and circuit activity, including potential non-neuronal contributions or artifacts.

12) Does the recording track prioritize collecting more recordings?

No. The emphasis is not on collecting recordings for their own sake, but on linking signal features to biological ground truth and clarifying how recording modalities map to specific physiological events so that signals can be more faithfully decoded and interpreted.

13) Are computational, modeling, or quantitative analysis approaches appropriate here?

Yes. The FOA welcomes work that combines experimental neuroscience with quantitative analysis, modeling, and data interpretation methods, as long as the core aim is understanding what signals mean or how stimulation produces biological effects (not building a new platform).

14) Can projects combine stimulation and recording?

Yes. The FOA notes that projects enabling the simultaneous use of multiple stimulation or recording technologies are allowed, especially where this supports cross-validation, ground-truthing, or understanding interactions among modalities (for example, pairing stimulation with concurrent recording or comparing signals across recording approaches).

15) What NIH mechanism supports this opportunity?

This is an NIH R01 grant mechanism.

16) Are clinical trials required?

No. Clinical trials are listed as optional. Applicants may propose clinical trial elements if appropriate and justified, but a clinical trial is not required.

17) Which agency is offering this opportunity?

The sponsoring agency is the National Institutes of Health (NIH), and the opportunity is part of the broader NIH BRAIN Initiative.

18) How does this relate to the NIH BRAIN Initiative?

The FOA is framed as supporting BRAIN Initiative goals related to measuring and manipulating neural circuit activity with greater specificity and reliability by strengthening the mechanistic understanding and interpretability of existing stimulation and recording tools.

19) What type of funding opportunity category is it?

It is categorized as discretionary and uses the standard NIH grant funding instrument.

20) Who is eligible to apply?

Eligibility is broad and includes: public and private institutions of higher education; nonprofits (with or without 501(c)(3) status); for-profit organizations (other than small businesses); small businesses; state, county, and city/township governments; special district governments; independent school districts; and public housing authorities/Indian housing authorities.

21) Are minority-serving institutions specifically included as eligible?

Yes. The eligible applicant pool explicitly includes Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).

22) Are tribal entities and community-based organizations eligible?

Yes. The FOA eligibility list includes certain tribal governments and organizations as well as faith-based or community-based organizations and regional organizations.

23) Are U.S. territories or possessions eligible to apply?

Yes. U.S. territories or possessions are included among eligible applicants.

24) Are federal agencies eligible to apply?

Yes. Eligible federal agencies are included in the stated eligibility.

25) Can non-U.S. (foreign) organizations apply?

Yes. The eligibility list explicitly includes non-U.S. (foreign) organizations.

26) What is the Funding Opportunity Number applicants should reference?

The Funding Opportunity Number provided is RFA-NS-20-006.

27) What CFDA program numbers are associated with this opportunity?

The source data lists multiple CFDA program numbers: 93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, and 93.867.

28) When was this opportunity created, and what does that imply?

The opportunity was created on 2020-01-02. This indicates it is a dated solicitation tied to a specific announcement rather than an always-open program announcement.

29) What is the closing date listed in the provided information?

The source data lists an original closing date of 2022-10-03.

30) Does the FOA emphasize short-term effects, long-term effects, or both?

Both. The stimulation track, in particular, calls out work on immediate biophysical and physiological responses as well as longer-term adaptive responses that can occur with repeated or chronic stimulation.

31) What kinds of biological levels or scales are emphasized for stimulation studies?

The FOA highlights multi-scale investigation, including membrane biophysics, cellular physiology, circuit-level effects, and adaptive responses over time.

32) What kinds of interpretive issues does the recording track want to resolve?

The recording track emphasizes understanding what signals represent biologically, how they correspond to underlying cellular and circuit activity, how non-neuronal contributions or artifacts may influence those signals, and how the information embedded in recordings can be decoded and interpreted more faithfully.